Unveiling mechanisms of resistance to immunotherapy: Tumor intrinsic JAK2 downmodulation leads to IFN-gamma deficient response and acquired resistance to T cell redirection therapies Contributor Nature Comms Behind the paper Unveiling mechanisms of resistance to immunotherapy: Tumor intrinsic JAK2 downmodulation leads to IFN-gamma deficient response and acquired resistance to T cell redirection therapies +2 Enrique Javier Arenas Lahuerta and 2 others Feb 23, 2021
